PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis

Biochemical Journal - United Kingdom
doi 10.1042/bj20040776
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Portland Press Ltd.

Related search

Reduced PAK1 Activity Sensitizes FA/BRCA-proficient Breast Cancer Cells to PARP Inhibition

Oncotarget
Oncology
2016English

PARP Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2018English

Brca2Deficiency Sensitizes Cells to PARP Inhibition

Cancer Research
Cancer ResearchOncology
2006English

Sulfated Polysaccharide-Protein Complex Sensitizes Doxorubicin-Induced Apoptosis of Breast Cancer Cells in Vitro and in Vivo

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

Magnetic Nanoparticles Sensitize McF-7 Breast Cancer Cells to Doxorubicin-Induced Apoptosis

World Journal of Surgical Oncology
SurgeryOncology
2012English

Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin

2016English

TAK1 Inhibitor 5z-7-Oxozeaenol Sensitizes Cervical Cancer to Doxorubicin-Induced Apoptosis

Oncotarget
Oncology
2017English

Inhibition of MEK/ERK1/2 Sensitizes Lymphoma Cells to Sorafenib-Induced Apoptosis

Leukemia Research
Cancer ResearchOncologyHematology
2010English

Sulforaphane Sensitizes Human Breast Cancer Cells to Paclitaxel‑induced Apoptosis by Downregulating the NF‑κB Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy